UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

þ ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 ~~2020~~, 2021

¨ ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________________ to __________________________

Commission file number 000-20333

Nocopi Technologies, Inc.

(Exact name of registrant as specified in its charter)

Maryland	87-0406496
~~Maryland~~	~~87-0406496~~
State or other jurisdiction of incorporation or organization	(I.R.S. Employer Identification No.)

480 Shoemaker Road, Suite 104, King of Prussia, PA	19406
(Address of principal executive offices)	(Zip Code)

(Registrant’s telephone number, including area code): ~~(610)~~ (610) 834-9600

Securities registered pursuant to Section 12(b) of the Act: None


Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Securities registered pursuant to section 12(g) of the Act:

Common Stock, Par Value $0.01

(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ¨☐ Yes þ☒No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ¨☐ Yes þ☒No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ☒Yes¨☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). þ☒Yes¨☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	¨ ☐	Accelerated filer	¨ ☐
Non-accelerated filer	þ ☒	Smaller reporting company	þ ☒
		Emerging Growth Company	¨ ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act of 1934) ¨☐ Yes þ☒No

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately ~~$6,454,000~~$12,681,000 as of June 30, ~~2020.~~2021.

As of March 17, ~~2021,~~2022, there were ~~67,353,690~~67,495,055 shares outstanding of the registrant’s common stock, $0.01 par value.

Documents Incorporated By Reference

Portions of the registrant’s definitive proxy statement to be filed in conjunction with the registrant’s ~~2020~~2022 annual meeting of stockholders are incorporated by reference in Part III of this Annual Report on Form 10-K. The proxy statement will be filed by the registrant with the Securities and Exchange Commission not later than 120 days after the end of the registrant’s fiscal year ended December 31, ~~2020.~~2021.

Table of Contents

				Page
			~~Page~~
PART I
~~PART I~~
	Item 1.	Business	1
	Item 1A.	Risk Factors	6 5
	Item 1B.	Unsolved Staff Comments	8
	Item 2.	Properties	8
	Item 3.	Legal Proceedings	8
	Item 4.	Mine Safety Disclosures	8

PART II
	Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	9
	Item 6.	~~Selected Financial Data~~ Reserved	9
	Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	9
	Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	13 14
	Item 8.	Financial Statements and Supplementary Data	13 14
	Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	14
	Item 9A.	Controls and Procedures	14
	Item 9B.	Other Information	14 15
	Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	15
~~PART III~~
PART III
	Item 10.	Directors, Executive Officers and Corporate Governance	15 16
	Item 11.	Executive Compensation	15 16
	Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	15 16
	Item 13.	Certain Relationships and Related Transactions, and Director Independence	15 16
	Item 14.	Principal Accounting Fees and Services	15 16

PART IV
	Item 15.	Exhibits, Financial Statement Schedules	16 17
	Item 16.	Form 10-K Summary	16 17

Forward-Looking Statements

This report on Form 10-K contains forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “we believe,” “we intend,” “may,” “should,” “will,” “could” and similar expressions denoting uncertainty or an action that may, will or is expected to occur in the future. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements.

Examples of forward-looking statements include, but are not limited to:

The ongoing impact of the COVID-19 coronavirus pandemic on our business operations, revenues, employees, suppliers and customers

Expected operating results, such as revenue growth and earnings

Anticipated levels of capital expenditures for fiscal year 2022 and beyond

Current or future volatility in market conditions

Our belief that we have sufficient liquidity to fund our business operations during the next twelve months

Strategy for customer retention, growth, product development, market position, financial results and reserves

Strategy for risk management

~~The ongoing impact of the COVID-19 coronavirus pandemic on our business operations, revenues, employees, suppliers and customers~~

~~Expected operating results, such as revenue growth and earnings~~

~~Anticipated levels of capital expenditures for fiscal year 2021 and beyond~~

~~Current or future volatility in market conditions~~

~~Our belief that we have sufficient liquidity to fund our business operations during the next twelve months~~

~~Strategy for customer retention, growth, product development, market position, financial results and reserves~~

~~Strategy for risk management~~

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the ~~following:~~following:

The extent to which the COVID-19 pandemic may impact our future financial and operational performance will be dependent on many factors that we may not be able to predict because they continue to change and evolve depending on both national and local circumstances, among them being government restrictions affecting our employees, customers and suppliers, changes in our revenues due to lower customer demand as a result of the pandemic and a potential inability to obtain raw materials due to lower availability. We continue to monitor the impact of COVID-19 on our business but we cannot accurately predict the extent to which it will adversely affect our future results of operations, financial condition or cash flows.

The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.

Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.

The impact of losing our intellectual property protections or the loss in value of our intellectual property.

Changes in customer demand.

The adequacy of our cash flow and earnings and other conditions which may affect our ability to timely service our debt obligations.

The occurrence of hostilities, political instability or catastrophic events.

Developments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards.

Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems.

The potential impact upon our business of the novel coronavirus COVID-19 pandemic that is affecting almost every country, including the United States.

Such other factors as discussed throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in this report.

The extent to which the COVID-19 pandemic may impact our future financial and operational performance will be dependent on many factors that we may not be able to predict because they continue to change and evolve depending on both national and local circumstances among them government restrictions affecting our employees, customers and suppliers, changes in our revenues due to lower customer demand as a result of the pandemic and a potential inability to obtain raw materials due to lower availability. We continue to monitor the impact of COVID-19 on our business but we cannot accurately predict the extent to which it will adversely affect our future results of operations, financial condition or cash flows.

~~Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.~~

~~The impact of losing our intellectual property protections or the loss in value of our intellectual property.~~

~~Changes in customer demand.~~

~~The adequacy of our cash flow and earnings and other conditions which may affect our ability to timely service our debt obligations.~~

~~The occurrence of hostilities, political instability or catastrophic events.~~

~~Developments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards.~~

~~Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems.~~

~~The potential impact upon our business of the novel coronavirus COVID-19 pandemic that is affecting almost every country, including the United States.~~

~~Such other factors as discussed throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in this report.~~

Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

PART I

Item 1.

Business

Background

Nocopi Technologies, Inc. develops and markets specialty reactive inks for applications in the large educational and toy products market. We also develop and market technologies for document and product authentication, which we believe can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers. Our website address is www.nocopi.com.

Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.

Effects of COVID-19

To serve our customers while also providing for the safety of our employees and service providers, we have adapted various steps to protect our employees. Any employee who is uncomfortable coming into our facilities may choose not to come in. We have a large enough facility to enable all of our employees to social distance and we follow Centers for Disease Control and Prevention (CDC) guidelines. Our production employees work with chemicals and they have always used masks, respirators, etc., even before COVID-19. As a result, we continue to maintain the same level of productivity and effectiveness as prior to the COVID-19 pandemic.

The impact of COVID-19 on our ~~Company’s~~Company had little effect on the financial results ~~for~~during the ~~year ended December 31, 2020 resulted primarily from a significant increase in~~first six months of 2021 as the ~~price~~shortage of raw materials used in certain of our Company’s products ~~caused by shortages of these ingredients~~experienced throughout 2020 as a ~~result~~consequence of the COVID-19 pandemic and the resultant price increases were at least temporarily eased, though still higher than pre-pandemic levels, so our Company’s gross margins on those products returned to similar levels as were experienced before the inception of the COVID-19 pandemic; however, during the last six months of 2021, certain of the Company’s licensees in the entertainment and toy products market who utilize printers in China to produce their products have been adversely affected by the cargo surge related to congestion experienced in certain Chinese ports due to a COVID-19 outbreak that began in the second quarter of 2021. The cargo surge continues to the present time, now adversely affecting major United States ports. The world-wide cargo surge along with a ~~mix~~container shortage resulted in significantly higher shipping costs during the second half of 2021. These congestion shipping related delays are likely to continue well into 2022. Certain of our Company’s licensees in the entertainment and toy products ~~purchased~~market have responded by deferring or scaling back production and size of future orders and, in some cases, rescheduling the shipping of completed orders. Ink orders from our Company’s licensed printers in China fell significantly in the second half of 2021 compared to earlier periods. These supply chain disruptions are being experienced by many businesses including our Company’s licensees. A continuance of these supply chain disruptions may negatively impact the number and value of orders placed by our ~~licensees’ third party~~Company’s licensed printers ~~toward certain~~in the entertainment and toy products market with ~~formulations that require ingredients whose prices have increased as~~ a ~~result of COVID-19. We expect these higher raw material prices to negatively affect subsequent periods until the shortages are alleviated. We expect future periods to see a similar~~resultant negative impact from COVID-19 and the various operational adjustments we made. The full extent of the impact to our Company due to the impact of the COVID-19 pandemic for future periods cannot be currently determined. The extent to which the COVID-19 pandemic may impact our future financial and operational performance will be dependent on many factors that we may not be able to predict because they continue to change and evolve depending on both national and local circumstances among them government restrictions affecting our employees, customers and suppliers, changes in our revenues due to lower customer demand as a result of the pandemic and a potential inability to obtain raw materials due to lower availability. We continue to monitor the impact of COVID-19 on our ~~business but we cannot accurately predict the extent to which it will adversely affect our future~~Company’s results of operations ~~financial condition or~~and cash ~~flows.~~flow in future periods.

To date, we have not suffered a drop off in ~~customer orders and~~ total earned royalties in the entertainment and toy products market as a result of COVID-19 ~~but we~~as retail demand continues to be strong for the products marketed by our licensees in the entertainment and toy products market; however, during the second half of 2021, reflecting the significantly higher shipping costs caused by the COVID-19 related cargo surge at major China and United States ports and the world-wide container shortage, ink orders from the printers of our licensees in the entertainment and toy products market were significantly below historical levels. We continue to experience a negative impact on revenues in our smaller anti-counterfeiting and anti-diversion products market due to ~~closures of~~reduced production activity at certain printing facilities that utilize these technologies and anticipate that these ~~closures~~conditions may continue for a period of time. We continue to retain licensing revenues at historical levels in the entertainment and toy products market through the current date despite the downturns in the overall economy. While the products of our licensees in the larger entertainment and toy products market are sold by both large and smaller retailers, some of whom remain open, and are also available for purchase online, we believe that revenues may not continue to be achieved at levels experienced to the current date due to the negative economic conditions that are expected to continue ~~throughout 2021~~over the balance of 2022 and beyond as a result of ~~COVID-19.~~COVID-19, its variants such as the Omicron variant identified in late 2021 and the newly identified BA.2 variant and other economic factors currently affecting the economy. A slowdown in overall consumer spending may affect the sales of products marketed by our licensees. Our major licensees in the entertainment and toy products market are large, well-known businesses in this market with whom we believe our long-term relationship will not be adversely affected by the current COVID-19 pandemic.

Entertainment and Toy Technologies and Products

Since 2004, we have marketed our Rub-it & Color technology to the entertainment and toy products market. This technology consists of specialty inks that are produced in a variety of colors and can be revealed by rubbing with a fingernail or other firm object such as a plastic pen cap. Rub-it & Color ink technology can be used for coloring books, activity kits, play sheets, single use place mats, greeting cards, board games, promotional products, or any other paper-based application that’s needs some “fun” factor added. Safe and non-toxic, Rub-it and Color conforms to ASTM D4236 and F-963 and other toxicology tests.

Every child loves to color, and every parent has a horror story about the cleanup. Our patented, revolutionary, and award-winning Rub-it & Color takes out all the messy stuff related to children’s coloring except the fun. No more crayons ground into the carpet and car upholstery. No more spilled paint on the rug. No more messy markers ruining clothes and furniture. Rub-it & Color ink technology can be used for coloring books, activity kits, play sheets, single use place mats, greeting cards, board games, promotional products, or any other paper-based application ~~that~~that’s needs some “fun” factor added. Safe and non-toxic, Rub-it and Color conforms to ASTM D4236 and F-963 and other toxicology tests.

We license our Rub-it & Color technology through various license agreements, including:

License agreement with a licensee who has a significant presence in the entertainment and toy products market. A license agreement, in effect from January 2012 through December 2017, permitted this licensee to exclusively market: (1) a specific line of products incorporating our technologies through a specific distribution channel but permitting us to license the covered technologies to others for applications and sale through channels of distribution not available to this licensee under the terms of the license, and (2) from January 2013 through December 2017, an additional technology on an exclusive basis in certain geographic areas of the world and on a non-exclusive basis in other geographic areas of the world. In early 2018, we entered into a new five-year license agreement with this licensee which permits the licensee to market products incorporating certain of our technologies, including the technologies permitted in the earlier license, on a non-exclusive basis throughout the world.

License agreement containing guaranteed minimum royalties over the initial term of the license, which have been met, with Bendon, Inc. (“Bendon”), an international, well-known children’s coloring and activity book publishing company that permits Bendon to exclusively market products with other characteristics that incorporate our technologies through a distinctly different channel of distribution. This four-year license agreement was completed in June 2015, replacing a previous three-year license agreement. In 2018, amendments to the license agreement were negotiated that (1) extend the license for a period of four years beginning in July 2019 containing guaranteed minimum royalty payments payable over the four-year period and (2) allow Bendon to: (a) market specific new technologies not covered in the license agreement, (b) expand certain rights relative to product content and design that were specifically excluded in the license agreement and (c) market merchandise permitted by the license through all channels of distribution, some of which were previously prohibited in the license agreement.

License agreement with a privately-held designer of creative educational products for children granting the licensee the non-exclusive right to utilize our Rub-it & Color ink technology in a newly-created vertical market in the United States. We receive a royalty based on units of product produced. The license originated in 2011 and was amended effective as of January 1, 2022 for a period of two years, now expiring in December 2023.

License agreement with a privately-held children’s meal entertainment program provider that allows the licensee to use our Rub-it & Color ink technology in children’s menus, placemats, butcher paper and certain other products for restaurant use and for sale in certain children’s retail outlets. The license originated in November 2012 and was renegotiated in December 2021 for an initial period of up to three years, expiring in December 2024.

License agreement with a privately-held international publisher of family products and publications based in Australia. The license originated in October 2015 and terminated in December 2018. The license agreement contained guaranteed minimum royalty payments and allowed the licensee to market certain products that incorporate specific technologies of our Company on an exclusive basis in certain countries and on a non-exclusive basis in other countries with the exclusion of the United States, Canada and Mexico. A new license containing guaranteed minimum royalty payments, allowing the licensee to market certain products that incorporate specific technologies of our Company on an exclusive basis in certain countries and on a non-exclusive basis in other countries with the exclusion of the United States, Canada and Mexico, was negotiated in November 2018. The new license, expanding the technologies that the licensee is authorized to incorporate into its products, became effective in January 2019 and terminates in October 2022. The licensee introduced products incorporating our technologies in 2016.

~~License agreement containing guaranteed minimum royalties over the initial term of the license, which have been met, with Bendon, Inc. (“~~~~Bendon~~”), an international, well-known children’s coloring and activity book publishing company that permits Bendon to exclusively market products with other characteristics that incorporate our technologies through a distinctly different channel of distribution. This four-year license agreement was completed in June 2015, replacing a previous three-year license agreement. In 2018, amendments to the license agreement were negotiated that (1) extend the license for a period of four years beginning in July 2019 containing guaranteed minimum royalty payments payable over the four-year period and (2) allow Bendon to: (a) market specific new technologies not covered in the license agreement, (b) expand certain rights relative to product content and design that were specifically excluded in the license agreement and (c) market merchandise permitted by the license through all channels of distribution, some of which were previously prohibited in the license agreement.

License agreement with a privately-held designer of creative educational products for children granting the licensee the exclusive right to utilize our Rub-it & Color ink technology in a newly-created vertical market in the United States. In addition to a license fee, we receive a royalty based on units of product produced. The license originated in 2011 and was renewed in June 2020 for a period of eighteen months.

Certain of our license agreements with licensees contain renewal options and/or guaranteed minimum royalties, while others do not. We cannot assure you that any of our existing licenses will be renewed or will generate significant operating revenues for our Company in the future. In each of the years ~~2020~~2021 and ~~2019,~~2020, we derived approximately ~~91%~~90% and ~~88%~~91%, respectively, of our total revenues from our licensees and their licensed printers in the entertainment and toy products market. We continue to pursue additional licensing opportunities for our Rub-it & Color ink technology in the large worldwide entertainment and toy products market through direct marketing efforts and attendance at trade shows. We also seek to renew existing license agreements with licensees.

Anti-Counterfeiting and Anti-Diversion Technologies and Products

Continuing developments in copying and printing technologies makes it easier than ever before to counterfeit a wide variety of documents. Product labels and packaging, retail receipts, event and transportation tickets and the like are all susceptible to counterfeiting, and product counterfeiting has long caused losses to manufacturers of brand name products. With improvements in the copying and printing technologies making it easier to counterfeit labeling and packaging, losses to businesses from such counterfeiting appear to have increased substantially.

Our COPIMARK and RUB & REVEAL technologies provide proprietary document authentication systems that are useful to businesses desiring to authenticate a wide variety of printed materials and products. Our COPIMARK system enables businesses to print invisibly on certain areas of a document. When authentication of certain documents is required, the invisible printing can be activated or revealed by use of a special highlighter pen. Other variations of the COPIMARK technology involve multiple color responses from a common pen, visible marks of one color that turn another color with the pen or visible and invisible marks that turn into a multicolored image. Our RUB & REVEAL system permits the invisible printing of an authenticating symbol or code that can be revealed by rubbing a fingernail over the printed area.

Both technologies provide users with the ability to authenticate documents and detect counterfeit documents. Applications include the authentication of documents having intrinsic value, such as merchandise receipts, checks, travelers' checks, gift certificates and event tickets, and the authentication of product labeling and packaging. When applied to product labels and packaging, our systems allow detection of counterfeit products, the labels and packaging of which would not contain the authenticating marks invisibly printed on the packaging or labels of the legitimate product.

Our marketing efforts for these technologies are focused on specific industries we believe may be affected by product counterfeiting. These technologies also combat product diversion (i.e. sale of legitimate products through unauthorized distribution channels or in unauthorized markets). Another of our related technologies, our invisible inkjet technology, permits manufacturers and distributors to track the movement of products from production to ultimate consumption when coupled with proprietary software. We anticipate that the “track and trace” capability provided by this technology will be attractive to brand owners and marketers and we hope that our ongoing marketing initiatives will result in additional revenues in the future; although we cannot assure you that this will occur.

We currently participate in the retail receipt and document fraud market through licensing arrangements with four printers and distributors in the United States and Canada who provide loss prevention products to retailers and other outlets. We market these technologies through the use of licensed printers and distributors and continue to use our available internal sales and technical resources to expand the number of licensees marketing our technologies in this market.

Contrast Technologies, formerly known as Euro-Nocopi, S.A., is a former affiliate of our Company that, since June 2003, has held a perpetual royalty-free license to exploit certain of our anti-counterfeiting and anti-diversion technologies in Europe.

Product Revenue

The following table illustrates the approximate percentage of our Company’s total revenues accounted for by each type of its products for each of the two last fiscal years:


	Year Ended December 31,						Year Ended December 31,
Product Type	2020			2019			2021			2020

Entertainment and Toy Technologies and Products		91	%		88	%		90	%		91	%
Anti-Counterfeiting and Anti-Diversion Technologies and Products		9	%		12	%		10	%		9	%

Marketing

~~Marketing~~

We have identified two major markets for our technologies and products, the entertainment and toy ~~product~~products market and the anti-counterfeiting/anti-diversion market. Our marketing approach focuses on the sufficient flexibility in our products and technologies and our ability to provide innovative, cost effective technologies for the entertainment and toy products market as well as solutions to a wide variety of counterfeiting, diversion and copier fraud problems. As a technology company, we generate revenues primarily by collecting license fees and royalties from market-specific businesses that incorporate our technologies into their products and, in certain cases, sales of our inks to these licensees and their designated manufacturers. We also license our technologies directly to end-users. Our current marketing efforts are focused on our developed technologies that can be utilized in geographic or market areas not contractually committed to an existing licensee on an exclusive basis. We presently market our technologies through our own employees, sales travel and attendance at trade shows.

Major Customers

During 2021, we made sales or obtained revenues equal to 10% or more of our Company’s 2021 total revenues from two non-affiliated customers who individually accounted for approximately 48% and 27%, respectively, of 2021 revenues of our Company. During 2020, we made sales or obtained revenues equal to 10% or more of our Company’s 2020 total revenues from two non-affiliated customers who individually accounted for approximately 62% and 16%, respectively, of 2020 revenues of our Company. During 2019, we made sales or obtained revenues equal to 10% or more of our Company’s 2019 total revenues from two non-affiliated customers who individually accounted for approximately 55% and 18%, respectively, of 2019 revenues of our Company.

Additional information concerning our major customers is contained in Note 1110 to our Financial Statements, attached as Appendix A to this Annual Report on Form 10-K.

Manufacturing

Our Company operates a small manufacturing facility for the manufacture of its security inks that is located at our corporate headquarters at 480 Shoemaker Road, Suite 104, King of Prussia, Pennsylvania 19406, and we subcontract the manufacture of certain of our applications (mainly certain printing inks and coatings) to third party manufacturers. Our current mix of manufacturing processes are suitable for our Company, for both economic and technical reasons, and we have no plans to alter this mix in the near future. We have established a quality control program that currently entails laboratory analysis of developed technologies; and when warranted, our specially trained technicians travel to third party production facilities to install equipment, train client staff and monitor the manufacturing process.

Patents

Our Company has been granted various patents in the United States, Canada, South Africa, Saudi Arabia, Australia, New Zealand, Japan, France, the United Kingdom, Belgium, the Netherlands, Germany, Austria, Italy, Sweden, Switzerland, Luxembourg, and Liechtenstein. We currently have patent protection on substantially all of our security inks including the RUB & REVEAL system, and on our Rub-it & Color technology. Our latest patent protects our newly developed technology that may have applications in the entertainment and toy products market.

In the United States and some other countries, patent applications are automatically published at a specified time after filing. Since we are obligated pay annuities from time to time on our patents to keep them in force, we annually evaluate our patent portfolio to determine which patents we will continue to maintain. In Europe, annuities for European patents are paid by Contrast Technologies, formerly known as Euro-Nocopi, S.A., since Europe is where they hold a perpetual royalty-free license to exploit certain of our anti-counterfeiting and anti-diversion technologies.

Research and Development

We have been involved in the research and development of our technologies since our inception. WeAlthough several years ago our adverse financial condition forced us to limit funding for research and development, we are presently actively conducting research and development activities in the following three areas, to the extent feasible: (1) refining our present family of products, (2) developing specific customer applications, and (3) expanding our technology into new areas of implementation. During the years ended December 31, ~~2020~~2021 and December 31, ~~2019,~~2020, we expended approximately ~~$173,500~~$181,500 and ~~$165,600,~~$173,500, respectively, on research and development. We cannot assure you that we will continue to have funds available to maintain our research and development activities at ~~comparable~~ current or increased levels.

Competition

~~Competition~~

Our Company has competitors in all segments of our business. The entertainment and toy products markets are highly competitive and includes numerous competitors. The loss prevention market also includes numerous competitors, including large publicly traded and privately-held companies as well as regional paper converters. In the area of document and product authentication and serialization, competitors offer competitive covert and overt surface marking technologies requiring decoding implements or analytical methods to reveal certain information that are marketed for the same anti-counterfeiting and anti-diversion purposes for which our Company markets its covert technologies. These include, among others, biological DNA codes, microtaggants, thermochromic, UV and infrared inks as well as encryption, 2D symbology and laser engraving. Nonetheless, we believe our patented and proprietary technologies provide a unique and cost-effective solution to the problem of counterfeiting and gray marketing in the document and product authentication markets it has traditionally sought to exploit.

We are a small operating company and many of our existing and potential competitors have substantially greater research and product development capabilities and financial, marketing and human resources than we do.

Employees

We currently have ~~four~~five full-time employees and ~~two~~one part-time ~~employees.~~employee. We believe that we have good relations with our employees.

Financial Information about Foreign and Domestic Operations

We conduct our business operations solely within the United States; however, we have licensees and customers in Europe, South America, Asia and Australia. These licensees and customers accounted for approximately 58% of our gross revenues in 2021 and approximately 74% of our gross revenues in ~~2020 and approximately 66% of our gross revenues in 2019.~~2020. Additional information concerning our foreign and domestic operations is contained in Note 1110 to our Financial Statements, attached as Appendix A to this Annual Report on Form 10-K.

Item 1A.

Risk Factors

Our Company’s operating results, financial condition and stock price are subject to certain risks, some of which are beyond its control. These risks could cause our Company’s actual operating and financial results to differ materially from those expressed in its forward-looking statements, including the risks described below and the risks identified in other documents which are filed and furnished with the United States Securities and Exchange Commission.

Spread of the Novel Strain of Coronavirus (“COVID-19”). A novel strain of coronavirus, COVID-19, that was first identified in Wuhan, China in December 2019 has surfaced in many countries around the world including the United States. The World Health Organization has declared COVID-19 to constitute a global pandemic. Certain state and local governments reacted by placing significant restrictions on businesses including a closure in Pennsylvania of non-essential businesses that was announced on March 20, 2020. While many Pennsylvania businesses have been allowed to reopen, often at limited capacity and with certain restrictions, as of the current date, there can be no assurances that future closures will be avoided. A requirement to close our Company for a considerable period of time could result in a negative impact on our Company’s financial condition and results of operations. Additionally, as our Company imports certain raw materials from China, if an extended disruption of the supply of these raw materials were to occur, our ability to produce products for sale to our customers could be negatively impacted. Further, restrictions on our customers and licensees in areas affected by the COVID-19 could adversely affect our results of operations and financial condition. We cannot predict the scope or magnitude of the negative effect that may result from the impact of the COVID-19 pandemic on the Company’s financial condition and results of operations.

~~The~~The COVID-19 pandemic will continue to negatively impact our results of operations, cash flow and financial position. The negative impact of COVID-19 on our Company’s financial results during 2020 resulted primarily from a significant increase in the price of raw materials used in certain of our Company’s products caused by shortages of these ingredients as a result of the COVID-19 pandemic along with a mix of our Company’s products purchased by our licensees’ third party printers toward certain products with formulations that require ingredients whose prices have increased as a result of COVID-19. ~~We expect~~During 2021, the shortage of raw materials used in certain of our Company’s products experienced throughout 2020 as a consequence of the COVID-19 pandemic and the resultant price increases were at least temporarily eased, though still higher than pre-pandemic levels, so our Company’s gross margins on those products returned to similar levels as were experienced before the inception of the COVID-19 pandemic; however, in the third quarter of 2021, certain of the Company’s licensees in the entertainment and toy products market who utilize printers in China to produce their products have been adversely affected by the cargo surge related to congestion experienced in certain Chinese ports due to a COVID-19 outbreak that began in the second quarter of 2021. The cargo surge continues to the present time, now adversely affecting major United States ports. The world-wide cargo surge along with a container shortage resulted in significantly higher shipping costs during the second half of 2021. Certain of our Company’s licensees in the entertainment and toy products market have responded by deferring or scaling back production and size of future orders and, in some cases, rescheduling the shipping of completed orders. Ink orders from our Company’s licensed printers in China fell significantly in the second half of 2021 compared to earlier periods. These supply chain disruptions are being experienced by many businesses including our Company’s licensees. A continuance of these ~~higher raw material prices to~~supply chain disruptions may negatively ~~affect subsequent periods until~~impact the ~~shortages are alleviated.~~number and value of orders placed by our Company’s licensed printers in the entertainment and toy products market with a resultant negative impact on our Company’s results of operations and cash flow in future periods.

Other disruptions to our business operations due to COVID-19 with a resultant impact on our results of operations are expected to continue to occur as a result of quarantines of employees and suppliers in areas affected by the outbreak, availability of raw materials required to manufacture our products, disruption of supply chains that provide our raw materials, price increases of raw materials and supplies used in our production processes, facility closures of domestic and international customers who purchase and use our products, and travel and logistics restrictions affecting our inbound and outbound shipments in connection with the COVID-19 outbreak. While we expect this global COVID-19 pandemic to continue to negatively impact our results of operations, cash flow and financial position, the related financial impact cannot be reasonably estimated at this time.

The extent to which the COVID-19 pandemic will negatively impact our results of operations, cash flow and financial position is highly uncertain and cannot be reasonably estimated at this ~~time.~~ time. The COVID-19 pandemic has created significant worldwide uncertainty, volatility and economic disruption. The extent to which COVID-19 will negatively impact our results of operations, cash flow and financial position is dependent upon numerous factors, many of which are highly uncertain, rapidly changing and uncontrollable. These factors include, but are not limited to: (i) the duration and scope of the pandemic; (ii) governmental, business and individual actions that have been and continue to be taken in response to the pandemic, including travel restrictions, quarantines, social distancing, work-from-home and shelter-in-place orders and shut-downs; (iii) the impact on U.S. and global economies and the timing and rate of economic recovery; (iv) potential adverse effects on the financial markets and access to capital; (v) potential goodwill or other impairment charges; and (vi) the ability of our licensees and other customers to sell products that utilize or incorporate our ~~technology.~~technology.

Access to Capital. Our Company anticipates that it may need to raise additional capital in the future to fund its historical and new business operations. Additional financing may not be available to us, due to, among other things, our Company not having a sufficient income stream, profit level, asset base eligible to be collateralized, or market for its securities. If we raise additional funds by issuing equity or convertible debt securities, the percentage ownership of our existing shareholders may be reduced, and these securities may have rights superior to those of our common stock. If adequate funds are not available to satisfy our long-term capital requirements, or if planned revenues are not generated, we may be required to substantially limit our operations or cease operations altogether. We cannot assure you that, if required, we will be successful in obtaining additional financing in sufficient amounts to fund our ongoing business operations.

Dependence on Major Customers. We are dependent on our licensees to develop new products and markets that will generate increases in its licensing and product revenues. The inability of our licensees to maintain at least current levels of sales of products utilizing our technologies could adversely affect our operating results and cash flow. To the extent that our licensees are adversely affected by negative economic conditions such as those that may result from the present COVID-19 pandemic, our revenues may also be negatively impacted. We derive a significant percentage of our revenues through licensing relationships with two major customers. Revenues obtained directly from these customers and indirectly, through the customers’ third party licensed printers, equaled approximately ~~86%~~85% of our Company’s revenues in ~~2020.~~2021. Receivables from these two licensees and their third party authorized printers were approximately ~~91%~~96% of our Company’s net accounts receivable at December 31, ~~2020.~~2021. One of the license agreements expires in 2023 and contains guaranteed minimum royalties, which historically are met. The other license agreement expires in 2022. Both license agreements contain renewal options; but there can be no assurances that one or both of the licenses will continue in force at the same or more favorable terms beyond their current termination dates, nor can there be any assurances that the relationships with these two licensees will generate increased revenues for our Company in the future.

Possible Inability to Develop New Business. Our management believes that any significant improvement in our Company’s cash flow must result from increases in revenues from traditional sources and from new revenue sources. Our Company’s ability to develop new revenues may depend on the extent of both its marketing activities and its research and development activities, both of which are limited. We cannot assure you that the resources that our Company can devote to marketing and to research and development will be sufficient to increase its revenues to levels that will enable it to maintain positive operating cash flow in the future.

Inability to Obtain Raw Materials and Products for Resale. Our Company’s adverse financial condition in years prior to 2016 has required it from time to time to significantly defer payments due to (i) vendors who supply raw materials and other components of its security inks, (ii) providers of professional and other services and (iii) certain employees to whom salary and sales commissions are owed. As a result, the Company is required to pay cash in advance of shipment to certain of its suppliers. The inability to obtain materials on a timely basis and the possibility that certain vendors may permanently discontinue supplying our Company with needed products and services may result in delayed shipments to customers and further impact our Company’s ability to service its customers, thereby adversely affecting our Company’s relationships with its customers and licensees. We cannot assure you that our Company will be able to maintain its vendor relationships in an acceptable manner.

Uneven Pattern of Quarterly and Annual Operating Results. Our Company’s revenues, which are derived primarily from licensing and sales of products incorporating its technologies as well as royalties from these products, are difficult to forecast; such forecasting difficulty is due to, among other reasons, the long sales cycle of our Company’s technologies, the potential for customer delay or deferral of implementation of our Company’s technologies, the size and timing of inception of individual license agreements, the success of our Company’s licensees and strategic partners in exploiting the market for the licensed products, modifications of customer budgets, and uneven patterns of royalty revenue and product orders. As our revenue base is not substantial, delays in the finalization of license contracts, the implementation of the technology to initiate the revenue stream and the ordering decisions of customers can have a material adverse effect on our Company’s quarterly and annual revenue expectations. As our operating expenses are substantially fixed, income expectations will be subject to a similar adverse outcome. As licensees for the entertainment and toy products markets are added, the predictability of our Company’s revenue stream may be further impacted.

Volatility of Stock Price. The market price for our common stock has historically experienced significant fluctuations and may continue to do so. With the exception of 2007, 2013, 2014 and 2016 through ~~2020~~2021 from its inception, our Company has operated at a loss and it has not produced revenue levels traditionally associated with publicly-traded companies. Our common stock is not listed on a national or regional securities exchange and, consequently, our Company receives limited publicity regarding its business achievements and prospects. Additionally, securities analysts and traders do not extensively follow our stock and it is thinly traded. The market price for our common stock may be affected by announcements of new relationships or modifications to existing relationships. The stock prices of many developing public companies, particularly those with small capitalizations, have experienced wide fluctuations not necessarily related to operating performance. Such fluctuations may adversely affect the market price of our Company’s common stock.

7

Intellectual Property. Our Company relies on a combination of protections as may be available under applicable domestic, foreign or international patent, trademark and trade secret laws. We also rely on confidentiality, non-analysis and licensing agreements to establish and protect our rights in its proprietary technologies. While we attempt to protect these rights, our technologies may be compromised through reverse engineering, independent invention or other means. In addition, our ability to enforce our intellectual property rights through appropriate legal action has been and will continue to be limited by its tight liquidity. We cannot assure you that our Company will be able to protect the basis of its technologies from discovery by third parties or to preclude third parties from conducting activities that infringe on our Company’s rights. Our Company’s tight liquidity adversely impacts our ability to obtain patent protection on our intellectual property and to maintain protection on previously issued patents. We cannot assure you that we will be able to continue to prosecute new patents and maintain issued patents. As a result, our customer and licensee relationships could be adversely affected, and the value of our technologies and intellectual property (including their value upon liquidation) could be substantially diminished.

Economic Conditions. Our Company’s revenue is susceptible to changes in general economic conditions. Our sales, liquidity and overall results of operations may be negatively affected by decreasing consumer confidence, slowdowns in consumer spending or other downturns in the U.S. economy as a whole or in any geographic markets from which we derive revenue. In addition, these factors may result in decreased customer and licensee demand for our products and may negatively impact our ability to develop new customers and licensees. Due to uncertainties surrounding the worldwide economy, particularly in light of the COVID-19 pandemic, the Russia-Ukraine war and the supply chain disruptions related to both, we are unable to predict the effect of such conditions on our customers and licensees. Consequently, we cannot predict the scope or magnitude of the negative effect resulting from ongoing global financial uncertainties or economic slowdowns.

Potential undetected material weakness in internal controls. Our ~~Annual Report~~annual report does not include an attestation report of our Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit our Company to provide only management’s attestation in this ~~Annual Report.~~annual report. As a result, a material weakness in our internal controls may remain undetected for a longer period.

Item 1B.
Unresolved Staff Comments

None.

Item 2.
Properties

Our corporate headquarters, research and ink production facilities are located at 480 Shoemaker Road, Suite 104, King of Prussia, Pennsylvania 19406. These premises consist of approximately 6,100 square feet of leased space. Our lease commenced in January 2014 and expires in April 2024. Current monthly rent under this lease is ~~$4,443;~~$4,467; this amount escalates an amount of approximately three percent each year. In addition to rent, we are also responsible for our pro-rata share of the operating costs of the building.

We incurred leasehold improvement expenditures of approximately ~~$27,800~~$58,400 through March 17, ~~2021,~~2022, and we believe that additional leasehold improvement expenditures will not be significant. We consider this space adequate for our current needs and additional space is available as needed.

Item 3.
Legal Proceedings

None.

Item 4.
Mine Safety Disclosures

Not applicable.

8

PART II

Item 5.
Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity Securities

Market Information

Our common stock is traded on the OTC Pink tier of the over-the-counter (“OTC”) market under the symbol "NNUP". Investors can find Real-Time quotes and market information on our Company on www.otcmarkets.com. Any over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

Shareholders

As of March 17, ~~2021,~~2022, there were approximately ~~525~~520 holders of our common stock, including The Depository Trust Company, which holds shares of our common stock on behalf of an indeterminate number of beneficial owners.

Dividends

Our Company does not pay any cash dividends on its common stock. Our Business Loan Agreement with Santander Bank, N.A. restricts our ability to pay cash dividends on our common stock and it will continue to do so for the foreseeable future.

Securities Authorized for Issuance under Equity Compensation Plans

None.

Recent Sales of Unregistered Securities

Date
~~Date~~
Security/Value
~~July 2020~~
May 2021
Common Stock – ~~5,758,992~~141,365 shares of common stock at ~~the price of at $0.025 per share issued pursuant to the conversion of $97,900 of 7% convertible debentures plus approximately $46,000 of accrued interest.~~
~~July 2020~~
~~Common Stock – 550,000 shares of common stock at the price of at~~ $0.02 per share ~~issued~~ pursuant to warrant exercises for total proceeds of ~~$11,000.~~
approximately $2,800.

No underwriters were utilized, and no commissions or fees were paid with respect to the above ~~transaction.~~ transactions. We relied on Section 4(a)(2) and/or Regulation D of the Securities Act of 1933, as amended, since the transactions did not involve any public offering.

Issuer Repurchases of Equity Securities

None.

Item 6.[Reserved]
~~Selected Financial Data~~

Not Applicable.

Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations

The information in this report contains forward-looking statements. All statements other than statements of historical fact made in this report are forward looking. In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements. These forward-looking statements can be identified by the use of words such as “believes,” “estimates,” “could,” “possibly,” “probably,” anticipates,” “projects,” “expects,” “may,” “will,” or “should” or other variations or similar words. No assurances can be given that the future results anticipated by the forward-looking statements will be achieved. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Our actual results may differ significantly from management’s expectations.

9

The following discussion and analysis should be read in conjunction with our ~~Audited Financial Statements,~~financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

Background Overview

Nocopi Technologies, Inc. develops and markets specialty reactive inks for applications in the large educational and toy products market. We also develop and market technologies for document and product authentication, which we believe can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.

Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.

Results of Operations

Our Company’s revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.

Our Company recognizes revenue on its lines of business as follows:

a. License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;
b. Product sales are recognized at the time of the transfer of goods to customers at an amount that our Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and
c. Fees for technical services are recognized at the time of the transfer of services to customers at an amount that our Company expects to be entitled to in exchange for the services, which is when the service has been rendered.
a.
~~License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;~~
b.
Product sales are recognized at the time of the transfer of goods to customers at an amount that our Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and
c.
Fees for technical services are recognized at the time of the transfer of services to customers at an amount that our Company expects to be entitled to in exchange for the services, which is when the service has been rendered.

We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.

Both the absolute amount of our Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on our Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. We cannot predict whether COVID-19 will materially affect our licensing fees or the demand for our products in ~~2021~~2022 and beyond. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when our Company agrees to revise such terms, revenues from the customer may be affected.

10

Comparison of the Years ended December 31, ~~2020~~2021 and ~~2019~~2020

Revenues for ~~2020~~2021 were ~~$2,658,700, an increase~~$1,951,900, a decrease of approximately 5%27%, or ~~$121,300,~~$706,800, from ~~$2,537,400~~$2,658,700 in ~~2019.~~2020.

Licenses, royalties and fees ~~decreased~~increased in ~~2020~~2021 by approximately 6%9%, or ~~$49,800,~~$65,900, to $809,900 from $744,000 ~~from $793,800~~ in ~~2019.~~2020. The ~~decrease~~increase in licenses, royalties and fees in 2021 compared to 2020 is due primarily to ~~lower guaranteed licensing revenue of approximately $200,000 in the first six months of 2020~~higher royalties from ~~one licensee~~our Company’s licensees in the entertainment and toy products market due to ongoing strong retail demand for these products offset in part by lower revenues from our licensees in the security markets. We cannot assure you that the marketing and product development activities of our Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for our Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions being experienced worldwide as a result of the ~~adoption of ASU 214-09,~~ ~~Revenue from Contracts~~COVID-19 pandemic that is continuing to negatively impact all worldwide economies along with ~~Customers~~ the massive international supply chain disruptions currently being experienced. The products marketed by the Company’s major licensees in the ~~second quarter of 2018.~~entertainment and toy products markets are produced in China. Trans-Pacific ocean shipping has been negatively affected by container shortages and port delays both in the United States and China.

Product and other sales ~~increased~~decreased by ~~$171,100,~~$772,700, or approximately ~~10%~~40%, to $1,142,000 in 2021 from $1,914,700 in ~~2020 from $1,743,600 in 2019.~~2020. The ~~higher~~lower level of ink sales in ~~2020~~2021 compared to ~~2019~~2020 is due primarily to ~~higher~~lower ink requirements of the ~~licensed third-party~~third party authorized printers used by ~~the~~two of our Company’s major licensees in the entertainment and toy products market. Sales of ink to the licensed printers of its licensees in the entertainment and toy products market were approximately ~~$222,900 higher~~$751,500 lower in ~~2020~~2021 compared to ~~2019.~~2020. Sales of security ink to ~~the~~our Company’s licensees in the retail receipt and document fraud market decreased by approximately ~~$30,300~~$12,900 in ~~2020~~2021 compared to ~~2019~~2020 due primarily to reduced demand related to COVID-19 closures of retail outlets commencing in 2020 and continuing during ~~2020.~~2021.

Our Company derived ~~$2,419,000,~~$1,758,200, or approximately ~~91%~~90% of total revenues, from licensees and their licensed printers in the entertainment and toy products market in ~~2020~~2021 compared to ~~$2,223,900,~~$2,419,000, or approximately ~~88%~~91% of total revenues, in ~~2019.~~2020. The ~~increase~~decrease in revenues from our licensees and their authorized printers in the entertainment and toy products market in ~~2020~~2021 compared to ~~2019~~2020 is due primarily to ~~higher~~lower ink sales to the authorized printers of our Company’s licensees in the entertainment and toy products market in ~~2020~~2021 compared to ~~2019~~2020 offset in part by ~~lower guaranteed~~higher licensing revenue ~~of approximately $200,000~~ in ~~the first six months of~~2021 compared to 2020 from one licensee in the entertainment and toy products ~~market as a result of the adoption of ASU 214-09,~~ ~~Revenue from Contracts with Customers~~ ~~in the second quarter of 2018.~~market. Our Company’s licensees in the entertainment and toy products market continue to develop new products for this market and improve their current offerings; however, their sales will be affected by marketplace reaction to the new and improved products, economic conditions that influence this market segment and the economy as a whole. Revenues that the Company derives from these licensees will be similarly affected. We cannot assure you that the marketing and product development activities of licensees in the entertainment and toy products market will produce increased revenues for the Company in future periods, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions currently being experienced worldwide as a result of ~~COVID-19.~~COVID-19 and its variants including the Omicron variant identified in 2021 and the newly identified BA.2 variant.

Our Company’s gross profit decreased to $1,213,800, or approximately 62% of revenues, in 2021 from $1,535,000, or approximately 58% of revenues, in ~~2020 from $1,695,700, or approximately 67% of revenues, in 2019.~~2020. The lower gross profit in ~~2020~~2021 compared to ~~2019~~2020 results primarily from lower licenses, royalties and fees due to the adoption of Topic 606 in 2018 along with significant increases in the price of certain raw materials related to the impact of the ongoing COVID-19 pandemic in 2020 offset in part by higher gross revenues from product and other sales ~~2020~~offset in part by higher licenses, royalties and fees in 2021 compared ~~to 2019.~~2020.

Licenses, royalties and fees have historically carried a higher gross profit than product sales, which generally consist of supplies or other manufactured products that incorporate the Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by our Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees. The lower gross profit in ~~2020~~2021 compared to ~~2019~~2020 reflects lower gross revenues from product and other sales offset in part by higher gross revenues from licenses, royalties and fees ~~offset~~ in ~~part by higher product and other sales in 2020~~2021 compared to ~~2019.~~2020.

As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both gross profit from licenses, royalties and fees as well as overall gross profit. Due primarily to the ~~lower~~higher revenues from licenses, royalties and fees in ~~2020~~2021 compared to ~~2019,~~2020, the gross profit from licenses, royalties and fees ~~decreased~~increased to approximately ~~70%~~79% of revenues from licenses, royalties and fees in ~~2020~~2021 from approximately ~~79%~~70% in ~~2019.~~2020.

11
The gross profit, expressed as a percentage of revenues, of product and other sales is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. The gross profit from product and other sales decreased to approximately 50% of revenues in 2021 compared to approximately 53% of revenues ~~in 2020 compared to approximately 61% of revenues 2019.~~2020. The decrease in ~~2020~~gross profit in 2021 compared to ~~2019~~2020 is due ~~to: a)~~primarily to significantly lower ink shipments to the third party authorized printer used by one of our Company’s major licensees in the entertainment and toy products market offset in part by (a) a ~~significant increase~~decline in the cost of certain raw materials utilized by ~~our~~the Company in the manufacture of certain of its products as ~~a result~~prices of ~~price increases related~~these raw materials that had increased in 2020 due to the impact of the ongoing COVID-19 pandemic on the availability and supply of these raw materials have been at least temporarily eased in ~~2020 compared to 2019 (we are not passing along these cost increases to our customers at this time); b) an unfavorable~~2021, and (b) a favorable mix of products sold whereby the ~~increases in~~ purchases of ~~our~~the Company’s products by the licensed printers of its licensees in the entertainment and toy products market in ~~2020~~2021 compared to ~~2019~~2020 were of higher margin products manufactured by ~~our Company whose raw material prices were most affected by shortages created by~~ the ~~COVID-19 pandemic and c) increased production salaries related to a staffing addition, higher duties and equipment depreciation in 2020 compared to 2019.~~Company.

Research and development expenses were $181,500 in 2021 compared to $173,500 in ~~2020 compared to $165,600 in 2019.~~2020. The increase in ~~2020~~2021 compared to ~~2019~~2020 resulted primarily from ~~higher salary~~product development expense in ~~2020~~2021 compared to ~~2019.~~2020.

Sales and marketing expenses were $287,700 in 2021 compared to $356,400 in ~~2020~~2020. The decrease in 2021 compared to ~~$329,900 in 2019. The increase in~~ 2020 ~~compared to 2019~~ is due primarily to ~~higher~~lower commission expense on the ~~higher~~lower level of revenues in ~~2020~~2021 compared to ~~2019.~~2020.

General and administrative expenses increased to $719,400 in 2021 from $526,100 in ~~2020 from $393,900 in 2019.~~2020. The increase in ~~2020~~2021 compared to ~~2019~~2020 is due primarily to significantly higher legal expenses in 2021 compared to 2020 offset in part by lower corporate relations ~~and salary~~ expenses in ~~2020~~2021 compared to ~~2019.~~2020.

Other income (expenses) in 2020 ~~and 2019~~ included interest on convertible debentures that were held by seven investors and interest income on invested funds.

Income taxes in ~~2020~~2021 and ~~2019~~2020 resulted from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

Our lower net income of ~~$508,000~~$49,400 in ~~2020~~2021 compared to net income of ~~$754,900~~$508,000 in ~~2019~~2020 resulted primarily from a lower gross profit on a lower level of ~~licenses, royalties~~product and ~~fees, higher cost of revenues~~other sales and higher operating expenses in ~~2020~~2021 compared to ~~2019 offset in part by the reversal of income taxes in the first quarter of~~ 2020.

Our management does not believe that inflation and changing prices, with the exception of increases in the prices of certain raw materials that were most affected by shortages created by the COVID-19 pandemic in 2020, have had a significant effect on our revenues and results of operations during the years ended December 31, ~~2020~~2021 and December 31, ~~2019.~~2020.

Plan of Operation, Liquidity and Capital Resources

Our Company’s cash increased to $1,846,700 at December 31, 2021 from $1,362,800 at December 31, ~~2020 from $688,000 at December 31, 2019.~~2020. During ~~2020,~~2021, our Company generated ~~$702,400~~$512,700 from its operating activities, received ~~$11,000~~$2,800 upon the exercise of warrants and used ~~$38,600~~$31,600 for capital expenditures.

Our Company’s revenues ~~increased~~decreased approximately 5%27% to $1,951,900 in 2021 from $2,658,700 in 2020 ~~from $2,537,400 in 2019~~ primarily as a result of ~~higher~~lower sales of ink to the authorized printers of our Company’s licensees in the entertainment and toy products market ~~offset in part by lower royalty revenues from two licensees in the entertainment~~ and ~~toy products market along with~~ lower revenues from licensees in the anti-counterfeiting and anti-diversion technologies and products market reflecting the impact of the ongoing COVID-19 pandemic on this market offset in part by higher royalty revenues from a licensee in the entertainment and toy products market. Our Company’s gross profit decreased approximately 9%21% to $1,213,800 in 2021 from $1,535,000 in 2020 ~~from $1,695,700 in 2019~~ primarily as a result of ~~price increases related~~lower sales of ink to the impact of the ongoing COVID-19 pandemic on the availability and supply of certain raw materials in 2020 compared to 2019, along with an unfavorable mix of products sold whereby the increases in purchases of our Company’s products by the licensed printers of our ~~Company’s~~ licensees in the entertainment and toy products market and to licensees in ~~2020 compared to 2019 were of~~the anti-counterfeiting and anti-diversion technologies and products ~~manufactured by our Company whose raw material prices were most affected by shortages created by the COVID-19 pandemic.~~market.

Our Company’s total overhead expenses increased in ~~2020~~2021 compared to ~~2019,~~2020, our Company’s net interest income increased in ~~2020~~2021 compared to ~~2019~~2020 and our Company’s income tax expense ~~decreased~~increased in ~~2020~~2021 compared to ~~2019.~~2020. As a result of these factors, our Company generated net income of $49,400 in 2021 compared to $508,400 in ~~2020 compared to $754,900 in 2019.~~2020. Our Company had positive operating cash flow of ~~$702,400~~$512,700 in ~~2020.~~2021. At December 31, 2021, our Company had working capital of $3,197,500 and stockholders’ equity of $3,505,300. For the full year of 2020, our Company had net income of $508,400 and had positive operating cash flow of $702,400. At December 31, 2020, our Company had working capital of $2,801,100 and stockholders’ equity of $3,453,100. For the full year of 2019, our Company had net income of $754,900 and had positive operating cash flow of $360,600. At December 31, 2019, our Company had working capital of $1,835,300 and stockholders’ equity of $2,789,700.

12
In November 2018, our Company negotiated a $150,000 revolving line of credit (“Lineof Credit”) with a bank to provide a source of working capital, if required. The Line of Credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The Line of Credit is subject to an annual review and quiet period. There have been no borrowings under the Line of Credit since its inception. We may need to obtain additional capital in the future to further support the working capital requirements associated with our existing revenue base and to develop new revenue sources. We cannot assure you that we will be successful in obtaining such additional capital, if needed. We continue to maintain a cost containment program including curtailment, where possible, of discretionary research and development and sales and marketing expenses.

Our plan of operation for the twelve months beginning with the date of this ~~Annual Report~~annual report consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships our Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating the Company’s technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with our Company. We will continue to develop various applications for these licensees. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.

Our Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable our Company to generate additional revenues and positive cash flow.

Our Company has received, and may in the future seek, additional capital in the form of debt, equity or both, to support our working capital requirements and to provide funding for other business opportunities. Beyond the Line of Credit, we cannot assure you that if we require additional capital, that we will be successful in obtaining such additional capital, or that such additional capital, if obtained, will enable our Company to generate additional revenues and positive cash flow.

As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment in ~~2021~~2022 and beyond due to the COVID-19 virus and its effect on the global ~~economy.~~economy being experienced worldwide as a result of COVID-19 and its variants including the Omicron variant identified in late 2021 and the newly identified BA.2 variant. As a result, our revenues, results of operations and liquidity may be negatively impacted.

Contractual Obligations

We conduct our operations in leased facilities under a non-cancelable operating lease expiring in 2024. Future minimum lease payments under this operating lease at December 31, ~~2020~~2021 are: ~~$53,100 – 2021;~~ $54,600 – 2022; $56,200 – 2023 and $18,900 – 2024. Total rental expense under operating leases was $53,300 in each of the years ended December 31, ~~2020~~2021 and December 31, ~~2019.~~2020.

Recently Adopted Accounting Pronouncements

As of December 31, ~~2020,~~2021, there were no recently adopted accounting standards that had a material effect on our Company’s financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13,Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. The amendments in this Update affect loans, debt securities, trade receivables, and any other financial assets that have the contractual right to receive cash. The ASU requires an entity to recognize expected credit losses rather than incurred losses for financial assets. For public entities, the amendments are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. ASU No. 2019-10 extends the effective dates for two years for smaller reporting companies and nonpublic companies.

13
In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The amendments in this Update affect entities that issue convertible instruments and/or contracts in an entity’s own equity. For convertible instruments, the instruments primarily affected are those issued with beneficial conversion features or cash conversion features because the accounting models for those specific features are removed. However, all entities that issue convertible instruments are affected by the amendments to the disclosure requirements in this Update. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives under the current guidance because of failure to meet the settlement conditions of the derivatives scope exception related to certain requirements of the settlement assessment. The Board simplified the settlement assessment by removing the requirements (1) to consider whether the contract would be settled in registered shares, (2) to consider whether collateral is required to be posted, and (3) to assess shareholder rights. Those amendments also affect the assessment of whether an embedded conversion feature in a convertible instrument qualifies for the derivatives scope exception. Additionally, the amendments in this Update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Board decided to allow entities to adopt the guidance through either a modified retrospective method of transition or a fully retrospective method of transition.
Off-Balance Sheet Arrangements

None.

~~Item 7a.~~
Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Not Applicable.

Item 8.
Financial Statements and Supplementary Data

Our ~~Audited~~ Financial Statements are attached as Appendix A (following Exhibits) and included as part of this Form 10-K Report. A list of our ~~Audited~~ Financial Statements is provided in response to Item 15 of this Form 10-K Report.

Item 9.
Changes In And Disagreements With Accountants On Accounting and Financial Disclosure

None.

~~Item 9a.~~
Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, our Company evaluated the effectiveness and design and operation of its disclosure controls and procedures. Our Company’s disclosure controls and procedures are the controls and other procedures that we designed to ensure that our Company records, processes, summarizes, and reports in a timely manner the information that it must disclose in reports that our Company files with or submits to the Securities and Exchange Commission. Our principal executive officer and principal financial officer reviewed and participated in this evaluation. Based on this evaluation, our Company made the determination that its disclosure controls and procedures were effective.

14
Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal controls over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this evaluation, management has concluded that our internal control over financial reporting was effective as of December 31, ~~2020.~~2021.

Our Company’s internal control over financial reporting includes policies and procedures that (1) pertain to maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of the assets of our Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of our Company are being made only in accordance with authorizations of management and directors of our Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. In addition, the design of any system of controls is based in part on certain assumptions about the likelihood of future events, and controls may become inadequate if conditions change. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

This ~~Annual Report~~annual report does not include an attestation report of our Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit our Company to provide only management’s attestation in this ~~Annual Report.~~annual report.

Changes in Company Internal Controls

No change in our Company’s internal control over financial reporting occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

~~Item 9b.~~
Item 9B. Other Information

Not Applicable.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable.

15

PART III

Item 10.
Directors, Executive Officers and Corporate Governance

The information required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the ~~2021~~2022 Annual Meeting of Stockholders.

Item 11.
Executive Compensation

The information required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the ~~2021~~2022 Annual Meeting of Stockholders.

Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the ~~2021~~2022 Annual Meeting of Stockholders.

Item 13.
Certain Relationships and Related Transactions, and Director Independence

The information required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the ~~2021~~2022 Annual Meeting of Stockholders.

Item 14.
Principal Accountant Fees and Services

The information required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the ~~2021~~2022 Annual Meeting of Stockholders.

16

PART IV

Item 15.
Exhibits, Financial Statement Schedules

(a)
The following Audited Financial Statements are filed as part of this Form 10-K Report:
Report of Independent Registered Public Accounting Firm
Balance Sheets
~~Balance Sheets~~
Statements of Comprehensive Income
Statement of Stockholders’ Equity
Statements of Cash Flows
Notes to Financial Statements
(b)
The following exhibits are filed as part of this report.
See Exhibit Index.

Item 16.
Form 10-K Summary

None.

17

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NOCOPI TECHNOLOGIES, INC.
Date: March 30, ~~2021~~
2022
By:
/s/ Michael A. Feinstein, M.D.
Michael A. Feinstein, M.D.
Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature Title Date
~~Signature~~
~~Title~~
~~Date~~
/s/ Michael A. Feinstein, M.D.
Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)
March 30, ~~2021~~
2022
Michael A. Feinstein, M.D.
/s/ Rudolph A. Lutterschmidt
Vice President, Chief Financial Officer and Chief Accounting Officer (Principal Financial and Accounting Officer)
March 30, ~~2021~~
2022
Rudolph A. Lutterschmidt
/s/ Marc Rash
Director
March 30, ~~2021~~
2022
Marc Rash
/s/ Joseph Raymond
Director March 30, 2022
Joseph Raymond
/s/ Philip B. White
Director
March 30, ~~2021~~
2022
Philip B. White
/s/ Matthew C. Winger Director March 30, 2022
Matthew C. Winger

18

INDEX TO FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm
F-2
Balance Sheets as of December 31, ~~2020~~2021 and ~~2019~~
2020
F-3
Statements of Comprehensive Income for the Years ended December 31, ~~2020~~2021 and ~~2019~~
2020
F-4
Statement of Stockholders’ Equity for the Years ended December 31, ~~2020~~2021 and ~~2019~~
2020
F-5
Statements of Cash Flows for the Years ended December 31, ~~2020~~2021 and ~~2019~~
2020
F-6
Notes to Financial Statements
F-7

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and

Stockholders of Nocopi Technologies, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Nocopi Technologies, Inc. (the Company) as of December 31, ~~2020~~2021 and ~~2019,~~2020, and the related statements of comprehensive income, stockholders’ equity, and cash flows for each of the two years in the period ended December 31, ~~2020,~~2021, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, ~~2020~~2021 and ~~2019,~~2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, ~~2020,~~2021, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters
Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

/s/ Morison Cogen LLP (PCAOB-536)

We have served as the Company’s auditor since 2001.

Blue Bell, Pennsylvania
March 30, ~~2021~~2022

F-2

Nocopi Technologies, Inc.
Balance Sheets*

December 31

December 31

2020

2019

2021 2020
Assets

Current assets

Cash

$
1,362,800

$
688,000

$ 1,846,700 $ 1,362,800
Accounts receivable less allowance for doubtful accounts – 2020-$12,000; 2019-$5,000

1,280,800

1,352,300

Accounts receivable less $12,000 allowance for doubtful accounts 970,800 1,280,800
Inventory

324,800

127,900

422,700 324,800
Prepaid and other

97,800

135,000

160,000 97,800
Total current assets

3,066,200

2,303,200

3,400,200 3,066,200
Fixed assets

Leasehold improvements

27,800

24,200

58,400 27,800
Furniture, fixtures and equipment

163,700

252,500

164,100 163,700

191,500

276,700

Fixed assets, gross 222,500 191,500
Less: accumulated depreciation and amortization

104,300

206,600

134,200 104,300

87,200

70,100

Total fixed assets 88,300 87,200
Other assets

Long-term receivables

559,500

957,000

185,000 559,500
Operating lease right of use - building

160,300

202,000

Operating lease right of use – building 115,800 160,300
Other assets 300,800 719,800
Total assets $ 3,789,300 $ 3,873,200

719,800

1,159,000

Total assets

$
3,873,200

$
3,532,300

Liabilities and Stockholders’ Equity

Current liabilities

Convertible debentures

$
–

$
97,900

Accounts payable

5,700

44,300

$ 3,700 $ 5,700
Accrued expenses

178,600

231,600

151,500 178,600
Income taxes

36,300

52,400

— 36,300
Operating lease liability – current

44,500

41,700

47,500 44,500
Total current liabilities

265,100

467,900

202,700 265,100

Other liabilities

Accrued expenses, non-current

39,200

67,000

13,000 39,200
Deferred income taxes

–

47,400

Operating lease liability – non-current

115,800

160,300

68,300 115,800

155,000

274,700

Total other liabilities 81,300 155,000

Commitments and contingencies

Stockholders’ equity

Series A preferred stock, $1.00 par value

Authorized – 300,000 shares

Issued and outstanding – none

–

–

Common stock, $0.01 par value

Authorized – 75,000,000 shares

Issued and outstanding – 2020 - 67,353,690 shares; 2019 - 61,044,698 shares

673,500

610,400

Series A preferred stock, $1.00 par value, authorized – 300,000 shares, issued and outstanding – NaN — —
Common stock, $0.01 par value, authorized – 75,000,000 shares, issued and outstanding – 2021 - 67,495,055 shares; 2020 - 67,353,690 shares 675,000 673,500
Paid-in capital

12,575,800

12,483,900

12,577,100 12,575,800
Accumulated deficit

(9,796,200
)

(10,304,600
)
(9,746,800 ) (9,796,200 )

3,453,100

2,789,700

Total stockholders' equity 3,505,300 3,453,100
Total liabilities and stockholders’ equity

$
3,873,200

$
3,532,300

$ 3,789,300 $ 3,873,200

*The accompanying notes are an integral part of these financial statements.

F-3

Nocopi Technologies, Inc.
Statements of Comprehensive Income*

.

Years ended December 31

Years ended December 31

2020

2019

2021 2020
Revenues

Licenses, royalties and fees

$
744,000

$
793,800

$ 809,900 $ 744,000
Product and other sales

1,914,700

1,743,600

1,142,000 1,914,700

2,658,700

2,537,400

Total revenues 1,951,900 2,658,700

Cost of revenues

Licenses, royalties and fees

223,800

169,100

168,000 223,800
Product and other sales

899,900

672,600

570,100 899,900

1,123,700

841,700

Total cost of revenues 738,100 1,123,700
Gross profit

1,535,000

1,695,700

1,213,800 1,535,000

Operating expenses

Research and development

173,500

165,600

181,500 173,500
Sales and marketing

356,400

329,900

287,700 356,400
General and administrative

526,100

393,900

719,400 526,100

1,056,000

889,400

Total operating expenses 1,188,600 1,056,000
Net income from operations

479,000

806,300

25,200 479,000

Other income (expenses)

Interest income

18,200

11,700

20,700 18,200
Interest expense and bank charges

(6,900
)

(10,800
)
(2,200 ) (6,900 )

11,300

900

Total other income (expenses) 18,500 11,300
Net income before income taxes

490,300

807,200

43,700 490,300
Income taxes

(18,100
)

52,300

(5,700 ) (18,100 )
Net income

$
508,400

$
754,900

$ 49,400 $ 508,400

Net income per common share

Basic

$
.01

$
.01

$ .00 $ .01
Diluted

$
.01

$
.01

$ .00 $ .01

Weighted average common shares outstanding

Basic

64,052,777

59,443,207

67,436,153 64,052,777
Diluted

64,172,276

59,836,570

67,436,153 64,172,276

*The accompanying notes are an integral part of these financial statements.

F-4

Nocopi Technologies, Inc.
Statement of Stockholders’ Equity*
For the Period January 1, ~~2019~~2020 through December 31, ~~2020~~2021

Common stock

Paid-in

Accumulated

Common stock Paid-in Accumulated

Shares

Amount

Capital

Deficit

Total

Shares Amount Capital Deficit Total

Balance – January 1, 2019

58,616,716

$
586,200

$
12,440,000

$
(11,059,500
)

$
1,966,700

Issuance of common stock

720,000

7,100

18,300

25,400

Conversion of debentures and accrued interest to common stock

1,707,982

17,100

25,600

42,700

Net income

754,900

754,900

Balance – December 31, 2019

61,044,698

610,400

12,483,900

(10,304,600
)

2,789,700

Balance – January 1, 2020 61,044,698 $ 610,400 $ 12,483,900 $ (10,304,600 ) $ 2,789,700

Conversion of debentures and accrued interest to common stock

5,758,992

57,600

86,400

144,000

5,758,992 57,600 86,400 144,000

Exercise of warrants

550,000

5,500

5,500

11,000

550,000 5,500 5,500 11,000

Net income

508,400

508,400

508,400 508,400
Balance – December 31, 2020

67,353,690

$
673,500

$
12,575,800

$
(9,796,200
)

$
3,453,100

67,353,690 673,500 12,575,800 (9,796,200 ) 3,453,100

Exercise of warrants 141,365 1,500 1,300 2,800

Net income 49,400 49,400
Balance – December 31, 2021 67,495,055 $ 675,000 $ 12,577,100 $ (9,746,800 ) $ 3,505,300

*The accompanying notes are an integral part of these financial statements.

F-5

Nocopi Technologies, Inc.
Statements of Cash Flows*

Years ended December 31

Years ended December 31

2020

2019

2021 2020
Operating Activities

Net income

$
508,400

$
754,900

$ 49,400 $ 508,400
Adjustments to reconcile net income to net cash provided by operating activities

Depreciation and amortization

21,500

10,800

30,500 21,500
Bad debt expense

7,000

–

— 7,000
Deferred income taxes

(47,400
)

(61,400
)
— (47,400 )
Other assets

439,200

193,200

419,000 439,200
Other liabilities

(69,500
)

174,300

(70,700 ) (69,500 )
Common stock issued for services

–

25,400

859,200

1,097,200

Net income adjusted for non-cash operating activities 428,200 859,200
(Increase) decrease in assets

Accounts receivable

64,500

(773,300
)
310,000 64,500
Inventory

(196,900
)

5,600

(97,900 ) (196,900 )
Prepaid and other

37,200

(91,400
)
(62,200 ) 37,200
Increase (decrease) in liabilities

Decrease in liabilities
Accounts payable and accrued expenses

(45,500
)

108,700

(29,100 ) (45,500 )
Income taxes

(16,100
)

13,800

(36,300 ) (16,100 )

(156,800
)

(736,600
)
Total increase (decrease) in operating capital 84,500 (156,800 )
Net cash provided by operating activities

702,400

360,600

512,700 702,400

Investing Activities

Additions to fixed assets

(38,600
)

(73,400
)
(31,600 ) (38,600 )
Net cash used in investing activities

(38,600
)

(73,400
)
(31,600 ) (38,600 )

Financing Activities

Exercise of warrants

11,000

–

2,800 11,000
Net cash provided by financing activities

11,000

–

2,800 11,000
Increase in cash

674,800

287,200

483,900 674,800

Cash

Beginning of year

688,000

400,800

1,362,800 688,000
End of year

$
1,362,800

$
688,000

$ 1,846,700 $ 1,362,800

Cash paid for taxes

$
45,500

$
100,000

$ 38,000 $ 45,500

Supplemental Disclosure of Non-Cash Investing and Financing Activities

Operating lease right of use – building

$
–

$
241,100

Operating lease liability

$
–

$
(241,100
)
Accumulated depreciation and amortization

$
123,800

$
1,800

$ 600 $ 123,800
Furniture, fixtures and equipment

$
(123,800
)

$
(1,800
)
$ (600 ) $ (123,800 )
Convertible debentures

$
97,900

$
30,400

$ — $ 97,900
Accrued expenses

$
46,100

$
12,300

$ — $ 46,100
Common stock

$
(57,600
)

$
(17,100
)
$ — $ (57,600 )
Paid-in capital

$
(86,400
)

$
(25,600
)
$ — $ (86,400 )

*The accompanying notes are an integral part of these financial statements.

~~F-6~~

F-6
NOCOPI TECHNOLOGIES, INC.
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~

1.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020
1.Organization of the Company

Nocopi Technologies, Inc. (the “Company”) is organized under the laws of the State of Maryland. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the Entertainment and Toy and the Document and Product Authentication markets in the United States and foreign countries. Our Company operates in one principal industry segment.

2.
Significant Accounting Policies

Financial Statement Presentation – Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.

Estimates – The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.

Cash consists of demand deposits with a major U.S. bank.

Accounts receivable and credit policies – Accounts receivable are uncollateralized customer obligations due under normal trade terms generally requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.

The carrying amount of accounts receivable is reduced by an allowance that reflects management’s best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.

Inventory consists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.

Fixed assets are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.

Patent costs are charged to expense as incurred.

Revenues – Our Company follows Accounting Standards Update (“ASU”) 214-09, Revenue from Contracts with Customers (“Topic 606”), using the modified retrospective method. We recognize revenue from fixed fee licensees at a point in time when the term begins if the contract provides for patented ink technology only as it exists at the time that it is granted. However, for license agreements that provide for rights to future ink technology, revenue is recognized over the term of the license agreement. Revenue for per-unit license agreement is recognized in the period that the Company receives the related royalty report. Revenue for product sales is recognized upon shipment to the customer. There are no contract assets or contract liabilities and therefore no unsatisfied performance obligations. The Company does not offer any warranties, however, damaged products can be returned for credit or refund. For disaggregation of revenue by customers and geographic region, see Note ~~11.~~10.

Income taxes – Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

F-7
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020

~~F-7~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~

Fair value – The carrying amounts reflected in the balance sheets for receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. ~~The carrying amount of the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.~~

~~Convertible debentures~~, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, our Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.

Stock-based payments – Our Company accounts for stock-based compensation under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 718, "Compensation – Stock Compensation", which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. Our Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the vesting period or the requisite service periods using the straight-line method. Our Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASU 2017-07, with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed.

Earnings per share – Our Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share.Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.

The table below presents the computation of basic and diluted weighted average common shares outstanding:

Computation of Basic and Diluted Weighted Average Common Shares Outstanding

2020

2019

2021 2020
Basic shares outstanding

64,052,777

59,443,207

67,436,153 64,052,777
Incremental shares from assumed conversion of warrants

119,499

393,363

— 119,499
Diluted shares outstanding

64,172,276

59,836,570

67,436,153 64,172,276

Comprehensive income – Our Company follows FASB ASC 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since our Company has no items of other comprehensive income, comprehensive income is equal to net income.

~~F-8~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~

Recoverability of Long-Lived Assets

Our Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Our Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to our Company’s annual financial statements.

Recently Adopted Accounting Pronouncements

As of December 31, ~~2020,~~2021, there were no recently adopted accounting standards that had a material effect on our Company’s financial statements.

F-8
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020
Recently Issued Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13,Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. The amendments in this Update affect loans, debt securities, trade receivables, and any other financial assets that have the contractual right to receive cash. The ASU requires an entity to recognize expected credit losses rather than incurred losses for financial assets. For public entities, the amendments are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. ASU No. 2019-10 extends the effective dates for two years for smaller reporting companies and nonpublic companies.

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The amendments in this Update affect entities that issue convertible instruments and/or contracts in an entity’s own equity. For convertible instruments, the instruments primarily affected are those issued with beneficial conversion features or cash conversion features because the accounting models for those specific features are removed. However, all entities that issue convertible instruments are affected by the amendments to the disclosure requirements in this Update. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives under the current guidance because of failure to meet the settlement conditions of the derivatives scope exception related to certain requirements of the settlement assessment. The Board simplified the settlement assessment by removing the requirements (1) to consider whether the contract would be settled in registered shares, (2) to consider whether collateral is required to be posted, and (3) to assess shareholder rights. Those amendments also affect the assessment of whether an embedded conversion feature in a convertible instrument qualifies for the derivatives scope exception. Additionally, the amendments in this Update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Board decided to allow entities to adopt the guidance through either a modified retrospective method of transition or a fully retrospective method of transition.
3.
Concentration of Credit Risk

Certain financial instruments potentially subject our Company to concentrations of credit risk. These financial instruments consist primarily of cash and accounts receivables. At December 31, ~~2020,~~2021, our Company’s deposits with a financial institution were ~~$1,112,800~~$1,596,700 in excess of the FDIC deposit insurance coverage of ~~$250,000.~~$250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.

4.
Line of Credit

In November 2018, our Company negotiated a ~~$150,000~~$150,000 revolving line of credit with a bank to provide a source of working capital, if required. The line of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The line of credit is subject to an annual review and quiet period. There have been no borrowings under the line of credit since its inception.

5.
Convertible Debentures

During the third quarter of 2020, the holders of all previously outstanding convertible debentures totaling approximately ~~$97,900~~$97,900 that were due during the third quarter of 2020 elected to convert those debentures plus approximately ~~$46,100~~$46,100 of accrued interest into 5,758,992 shares of restricted stock of our Company. At December 31, 2021 and December 31, 2020, our Company had no convertible debentures outstanding. The convertible debentures bore interest at 7%7%. During the third quarter of 2019, the holders of approximately $30,400 of previously outstanding convertible debentures elected to convert those debentures plus approximately $12,300 of accrued interest into 1,707,982 shares of restricted stock of our Company.

F-9
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020
Our Company also granted warrants in earlier periods to purchase 691,365 shares of our Company’s common stock at ~~$0.02~~$0.02 per share to the holders of the debentures. The warrants ~~are~~were exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable. During the third quarter of 2020, holders of 550,000 warrants exercised their warrants to purchase a total of 550,000 shares of our Company’s common stock.

~~F-9~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~ During the second quarter of 2021, holders of the remaining 141,365 warrants that had been outstanding exercised their warrants to purchase a total of 141,365 shares of our Company’s common stock.

6.
~~Stockholders’ Equity~~

In October 2019, our Company issued 720,000 shares of restricted common stock to an investor relations firm as a portion of compensation for services. The common stock vested on a pro rata basis over one year. The fair value of the common stock amounting to $25,400 on the inception date of agreement was amortized to expense over the first year of the engagement.

7.
Other Income (Expenses)

Other income (expenses) in the ~~years~~year ended December 31, 2020 ~~and December 31, 2019~~ includes interest on convertible debentures that were held by seven investors.

8.
7.Income Taxes

There is no provision for federal income taxes for the years ended December 31, ~~2020~~2021 and December 31, ~~2019~~2020 due to the availability of ~~federal and state~~ net operating loss (NOL’s) carryforwards. At December 31, ~~2020~~2021 and December 31, ~~2019,~~2020, our Company had federal NOL’s approximating ~~$1,166,100~~$1,174,300 and ~~$1,622,000,~~$1,166,100, respectively and state NOL’s approximating ~~$2,647,000~~$2,638,800 and ~~$2,843,100,~~$2,647,000, respectively. The ~~federal and state~~ net operating losses at December 31, ~~2020~~2021 are available to offset future taxable income; however, if not utilized, they expire in varying amounts through the year 2032. The utilization of these NOL’s to reduce future income taxes will depend on the generation of sufficient taxable income prior to their expiration. There were no material temporary differences for the years ended December 31, ~~2020~~2021 and December 31, ~~2019.~~2020. Our Company has established a 100% valuation allowance of ~~$456,700~~$457,700 and ~~$454,200~~$456,700 at December 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively, for the deferred tax assets due to the uncertainty of their realization. The components for state income tax expense resulting from the limitation on the use of net operating losses are:

State Income Tax Expense

Year ended December 31

Year ended December 31

2020

2019

2021 2020
Current state taxes

$
29,400

$
52,400

$ (5,700 ) $ 29,300
Deferred state taxes

(47,400
)

–

— (47,400 )

$
(18,000
)

$
52,400

Income tax expense $ (5,700 ) $ (18,100 )

The reconciliation of the statutory federal rate to our Company’s effective tax rate follows:

2020

2019

Amount

%

Amount

%

Income tax at U.S. federal income tax rate

$
106,700

21

$
158,600

21

State tax net of federal tax effect

(18,100
)

(4
)

52,300

7

Other

15,800

3

–

–

Change in valuation allowance

(122,500
)

(24
)

(158,600
)

(21
)

$
(18,100
)

(4
)

$
52,300

7

~~F-10~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~
Reconciliation of the Statutory Fedreal Rate
2021 2020
Amount % Amount %

Income tax at U.S. federal income tax rate $ 9,700 21 $ 106,700 21

State tax net of federal tax effect (2,600 ) (5 ) (18,100 ) (4 )

Other (13,800 ) (30 ) 15,800 3

Increase in (utilization of ) operating losses 1,000 2 (122,500 ) (24 )
$ (5,700 ) (12 ) $ (18,100 ) (4 )

F-10
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020
The components of deferred tax assets and liabilities as of December 31, ~~2020~~2021 and ~~2019~~2020 are as follows:

Deferred Tax Assets and Liabilities

2020

2019

2021 2020

Deferred tax asset for NOL carryforwards

$
456,700

$
454,200

$ 457,700 $ 456,700

Deferred tax liability - other

–

(47,400
)

Valuation allowance

(456,700
)

(454,200
)
(457,700 ) (456,700 )

$
–

$
(47,400
)
Deferred tax liability $ — $ —

Our Company ~~has adopted the provisions of~~follows FASB ASC ~~740-10-50-15, “Unrecognized Tax Benefit Related Disclosures.” There were no~~740.10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination of whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information.
Our Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of ~~the date~~comprehensive income. As of ~~adoption and no~~January 1, 2021, our Company had 0 unrecognized tax benefits ~~at December 31, 2020. There was no change in~~and 0 charge during 2021, and accordingly, our Company did not recognize any interest or penalties during 2021 related to unrecognized tax ~~benefits during the year ended December 31, 2020 and there was no~~benefits. There is 0 accrual for uncertain tax positions as of December 31, ~~2020.~~2021.

Tax years from ~~2018~~2019 through ~~2020~~2021 remain subject to examination by U.S. federal and state tax jurisdictions.

9.
8.Commitments and Contingencies

Our Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2024.

Due to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments commencing January 1, 2019, using an estimated incremental borrowing rate of 6%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to ~~$241,100~~$241,100 with no0 cumulative-effect adjustment to the opening balance of accumulated deficit.

There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at December 31, 2020 are: $53,100 – 2021; $54,600 – 2022; $56,200 – 2023 and $18,900 – 2024.

Total lease expense under operating leases was ~~$53,300~~$53,300 in each of the years ended December 31, ~~2020~~2021 and December 31, ~~2019.~~

~~F-11~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~2020.

Maturities of lease liabilities are as follows:

Maturities of Lease Liabilities

Operating Leases

Operating Leases
Year ending December 31

2021

$
53,100

2022

54,600

$ 54,600
2023

56,200

56,200
2024

18,900

18,900
Total lease payments

182,800

129,700
Less imputed interest

(22,500
)
(13,900 )
Total

$
160,300

$ 115,800

F-11
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020
Our Company has an employment agreement, expiring in May ~~2022,~~2023, with Michael A. Feinstein, M.D., its Chairman of the Board and Chief Executive Officer. The employment agreement contains one-year renewal provisions that became effective after the original term. Dr. Feinstein receives base compensation of ~~$120,000~~$120,000 per year effective January 1, 2020 plus a performance bonus determined by our Company’s Board of Directors. Our Company has an employment agreement, expiring in March ~~2022,~~2023, with Terry W. Stovold, its Chief Operating Officer, whereby Mr. Stovold receives a salary set by our Company’s Board of Directors, currently set at ~~$75,000,~~$75,000, along with a commission of seven percent on sales generated by his efforts. The employment agreement contains one-year renewal provisions that became effective after the original term. Future minimum compensation payments under these employment agreements are: $195,000 to be paid in ~~2021~~2022 and $68,800 to be paid in ~~2022.~~2023.

From time to time, our Company may be subject to legal proceedings and claims that arise in the ordinary course of its business.

~~10.~~
9.Stock Options, Warrants and 401(k) Savings Plan

Our Company follows FASB ASC 718,Share Based Payment, which requires that the cost resulting from all share-based payment transactions be recognized in the Company’s financial statements. FASB ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of ~~operations~~comprehensive income based on their fair values.

At December 31, ~~2020,~~2021, our Company did not have an active stock option plan. Our Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no0 compensation expense recognized during the years ended December 31, ~~2020~~2021 and December 31, ~~2019~~2020 and there was no0 unrecognized portion of expense at December 31, ~~2020.~~2021.

At December 31, ~~2020,~~2021, our Company had ~~141,365~~0 outstanding warrants to purchase common stock of our ~~Company outstanding at an exercise price of $0.02 and expiring at various dates through July 2021. The warrants are held by two investors who acquired convertible debentures from our Company in 2014.~~

~~F-12~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~

Company. A summary of outstanding warrants follows:

Weighted

Exercise

Average

Number of

Price Range

Exercise

Shares

Per Share

Price

Outstanding at December 31, 2018 and December 31, 2019

691,365

$0.02

$0.02

Warrants exercised

550,000

0.02

0.02

Outstanding at December 31, 2020

141,365

$0.02

$0.02

Weighted average remaining contractual life (years)

.52

Weighted

Exercise

Average

Number of

Price Range

Exercise

Shares

Per Share

Price

Exercisable warrants at year end:

2020

141,365

$0.02

$0.02

Weighted average remaining contractual life (years)

.52

Outstanding Warrants
Weighted
Exercise Average
Number of Price Range Exercise
Shares Per Share Price
Outstanding at December 31, 2019 691,365 $0.02 $0.02
Warrants exercised 550,000   0.02   0.02
Outstanding at December 31, 2020 141,365   0.02   0.02
Warrants exercised 141,365   0.02   0.02
Outstanding at December 31, 2021 — 0.00 0.00

The aggregate intrinsic value of warrants outstanding and exercisable as of December 31, 2020 was approximately $17,700. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.145 for our Company’s common stock on December 31, 2020. At December 31, 2020, our Company has reserved 141,365 shares of common stock for possible future issuance upon the exercise of 141,365 warrants.

Our Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of our Company. There were no0 contributions charged to expense during ~~2020~~2021 or ~~2019.~~2020.

~~11.~~
10.Major Customer and Geographic Information

Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of our Company’s total revenues were:

Revenues from Non-affiliated Customers

Year ended December 31

Year ended December 31

2020

2019

2021 2020
Customer A

62%

55%

48 % 62 %
Customer B

16%

18%

27 % 16 %

F-12
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 2021 and 2020
Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:

Non-affiliated Customers with Accounts Receivable More Than 10%

December 31

December 31

2020

2019

2021 2020
Customer A

25%

26%

21 % 25 %
Customer B

65%

67%

74 % 65 %

Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition.

~~F-13~~

~~NOCOPI TECHNOLOGIES, INC.~~
~~NOTES TO FINANCIAL STATEMENTS~~
~~December 31, 2020 and 2019~~

Our Company’s revenues by geographic region are as follows:

Revenue by Geographic Region

Year ended December 31

Year ended December 31

2020

2019

2021 2020
North America

$
701,600

$
856,300

$ 812,800 $ 701,600
South America

2,200

–

4,100 2,200
Europe

–

600

Asia

1,845,500

1,630,500

1,041,300 1,845,500
Australia

109,400

50,000

93,700 109,400

$
2,658,700

$
2,537,400

$ 1,951,900 $ 2,658,700

1211. COVID-19
~~COVID-19~~

A novel strain of coronavirus (“COVID-19”) continues to spread in many countries around the world including the United States. In March 2020, the Governor of Pennsylvania declared a health emergency and issued an order to close all nonessential businesses until further notice. Our Company’s operations were deemed to be essential and thus remained open. Our Company’s results of operations were negatively affected in 2020 in part as a result of a significant increase in the cost of raw materials utilized by our Company in the manufacture of certain of its products as a result of price increases related to the impact of the ongoing COVID-19 pandemic on the availability and supply of these raw materials. During 2021, our Company’s results of operations were further affected by the cargo surge related to congestion experienced in certain Chinese ports due to a COVID-19 outbreak that began in the second quarter of 2021. The cargo surge continues to the present time, adversely affecting major United States ports. The world-wide cargo surge along with a container shortage resulted in significantly higher shipping costs during the second half of 2021 causing certain of our Company’s licensees in the entertainment and toy products market to defer or scale back production and size of future orders and, in some cases, to reschedule the shipping of completed orders. As the COVID-19 pandemic continues to spread with the Omicron variant and the newly identified BA.2 variant, any future financial impact cannot be reasonably estimated at this time.

F-13

Exhibit Index

The following Exhibits are filed as part of this Annual Report on Form 10-K:

Exhibit
~~Exhibit~~
Number
Description
Location
~~Number~~
~~Description~~
~~Location~~
3.1
~~3.1~~
Amended and Restated Articles of Incorporation
Incorporated by reference to the Company’s Form 10-Q filed on November 14, 2008
3.2
Second Amended and Restated Bylaws, Dated January 28, 2022
Incorporated by reference to the Company’s Form 8-K filed on February 2, 2022
3.3 Articles Supplementary relating to Nocopi Technologies, Inc.’s election to be subject to Sections 3-803, 3-804(a), 3-804(b) and 3-804(c) of the Maryland General Corporation Law
Incorporated by reference to the Company’s Form 8-K filed on ~~March 12, 2019~~October 29, 2021
4.1
Form of Certificate of Common Stock
Incorporated by reference to the Company’s Annual Report on Form 10-KSB filed on April 7, 2006
4.2
Securities registered under Section 12 of the Exchange Act
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 30, 2020
10.1†
Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan
Incorporated by reference to the Company’s Annual Report on Form 10-KSB filed on April 15, 1999
10.2
Director Indemnification Agreement
Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB filed on November 15, 1999
10.3
Officer Indemnification Agreement
Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB filed on November 15, 1999
10.4†
Employment Agreement with Michael A. Feinstein, M.D.
Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008
10.5†
Employment Agreement Amendment - Michael A. Feinstein, M.D.
Incorporated by reference to the Company’s Form 8-K filed on December 17, 2019
10.6†
Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 31, 2010
10.7†
Employment Agreement with Terry W. Stovold
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 30, 2012
10.8
Form of Convertible Debenture Purchase Agreement and Exhibits
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on September 11, 2015
10.9
Form of Letter Agreement re: Convertible Debenture Purchase Agreement Election
Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2019
10.10
Lease Agreement dated December 12, 2013 relating to premises at 480 Shoemaker Road, King of Prussia, PA 19406
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on September 11, 2015
10.11
Lease Extension Agreement dated September 28, 2018
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 29, 2019
10.12
Business Loan Agreement, Promissory Note and Commercial Security Agreement dated November 28, 2018 between the Company and Santander Bank
Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 29, 2019
10.13 Form of Letter Agreement re: Convertible Debenture Purchase Agreement Election Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2019
14.1
Code of Ethics
Incorporated by reference to the Company’s Annual Report on Form 10-KSB filed on March 31, 2005
31.1
Certification of Chief Executive Officer required by Rule 13a-14(a)
Filed herewith

31.2
Certification of Chief Financial Officer required by Rule 13a-14(a)
Filed herewith
32.1
Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Furnished herewith
101.INS
Inline XBRL Instance Document
(the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase
Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
———————
† Compensation plans and arrangements for executives and others.

Date
~~Date~~		Security/Value
~~July 2020~~ May 2021		Common Stock – ~~5,758,992~~141,365 shares of common stock at ~~the price of at $0.025 per share issued pursuant to the conversion of $97,900 of 7% convertible debentures plus approximately $46,000 of accrued interest.~~

~~July 2020~~		~~Common Stock – 550,000 shares of common stock at the price of at~~ $0.02 per share ~~issued~~ pursuant to warrant exercises for total proceeds of ~~$11,000.~~ approximately $2,800.


(a)	The following Audited Financial Statements are filed as part of this Form 10-K Report:

	Report of Independent Registered Public Accounting Firm
	Balance Sheets
	~~Balance Sheets~~
	Statements of Comprehensive Income

	Statement of Stockholders’ Equity

	Statements of Cash Flows

	Notes to Financial Statements

(b)	The following exhibits are filed as part of this report.

	See Exhibit Index.


	NOCOPI TECHNOLOGIES, INC.


Date: March 30, ~~2021~~ 2022	By:	/s/ Michael A. Feinstein, M.D.
		Michael A. Feinstein, M.D.
		Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)

Signature		Title	Date
~~Signature~~	~~Title~~	~~Date~~

/s/ Michael A. Feinstein, M.D.	Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)	March 30, ~~2021~~ 2022
Michael A. Feinstein, M.D.

/s/ Rudolph A. Lutterschmidt	Vice President, Chief Financial Officer and Chief Accounting Officer (Principal Financial and Accounting Officer)	March 30, ~~2021~~ 2022
Rudolph A. Lutterschmidt

/s/ Marc Rash	Director	March 30, ~~2021~~ 2022
Marc Rash

/s/ Joseph Raymond	Director	March 30, 2022
Joseph Raymond

/s/ Philip B. White	Director	March 30, ~~2021~~ 2022
Philip B. White

/s/ Matthew C. Winger	Director	March 30, 2022
Matthew C. Winger


Report of Independent Registered Public Accounting Firm	F-2

Balance Sheets as of December 31, ~~2020~~2021 and ~~2019~~ 2020	F-3

Statements of Comprehensive Income for the Years ended December 31, ~~2020~~2021 and ~~2019~~ 2020	F-4

Statement of Stockholders’ Equity for the Years ended December 31, ~~2020~~2021 and ~~2019~~ 2020	F-5

Statements of Cash Flows for the Years ended December 31, ~~2020~~2021 and ~~2019~~ 2020	F-6

Notes to Financial Statements	F-7


	December 31							December 31
	2020			2019				2021				2020
*Assets*
Current assets
Cash	$	1,362,800		$	688,000			$	1,846,700			$	1,362,800
Accounts receivable less allowance for doubtful accounts – 2020-$12,000; 2019-$5,000		1,280,800			1,352,300
Accounts receivable less $12,000 allowance for doubtful accounts								970,800				1,280,800
Inventory		324,800			127,900				422,700				324,800
Prepaid and other		97,800			135,000				160,000				97,800
Total current assets		3,066,200			2,303,200				3,400,200				3,066,200
Fixed assets
Leasehold improvements		27,800			24,200				58,400				27,800
Furniture, fixtures and equipment		163,700			252,500				164,100				163,700
		191,500			276,700
Fixed assets, gross								222,500				191,500
Less: accumulated depreciation and amortization		104,300			206,600				134,200				104,300
		87,200			70,100
Total fixed assets								88,300				87,200
Other assets
Long-term receivables		559,500			957,000				185,000				559,500
Operating lease right of use - building		160,300			202,000
Operating lease right of use – building								115,800				160,300
Other assets								300,800				719,800
Total assets							$	3,789,300			$	3,873,200
		719,800			1,159,000
Total assets	$	3,873,200		$	3,532,300
*Liabilities and Stockholders’ Equity*
Current liabilities
Convertible debentures	$	–		$	97,900
Accounts payable		5,700			44,300			$	3,700			$	5,700
Accrued expenses		178,600			231,600				151,500				178,600
Income taxes		36,300			52,400				—				36,300
Operating lease liability – current		44,500			41,700				47,500				44,500
Total current liabilities		265,100			467,900				202,700				265,100

Other liabilities
Accrued expenses, non-current		39,200			67,000				13,000				39,200
Deferred income taxes		–			47,400
Operating lease liability – non-current		115,800			160,300				68,300				115,800
		155,000			274,700
Total other liabilities								81,300				155,000

Commitments and contingencies

Stockholders’ equity
Series A preferred stock, $1.00 par value
Authorized – 300,000 shares
Issued and outstanding – none		–			–
Common stock, $0.01 par value
Authorized – 75,000,000 shares
Issued and outstanding – 2020 - 67,353,690 shares; 2019 - 61,044,698 shares		673,500			610,400
Series A preferred stock, $1.00 par value, authorized – 300,000 shares, issued and outstanding – NaN								—				—
Common stock, $0.01 par value, authorized – 75,000,000 shares, issued and outstanding – 2021 - 67,495,055 shares; 2020 - 67,353,690 shares								675,000				673,500
Paid-in capital		12,575,800			12,483,900				12,577,100				12,575,800
Accumulated deficit		(9,796,200	)		(10,304,600	)			(9,746,800	)			(9,796,200	)
		3,453,100			2,789,700
Total stockholders' equity								3,505,300				3,453,100
Total liabilities and stockholders’ equity	$	3,873,200		$	3,532,300			$	3,789,300			$	3,873,200


.	Years ended December 31						Years ended December 31
	2020			2019			2021			2020
Revenues
Licenses, royalties and fees	$	744,000		$	793,800		$	809,900		$	744,000
Product and other sales		1,914,700			1,743,600			1,142,000			1,914,700
		2,658,700			2,537,400
Total revenues							1,951,900			2,658,700

Cost of revenues
Licenses, royalties and fees		223,800			169,100			168,000			223,800
Product and other sales		899,900			672,600			570,100			899,900
		1,123,700			841,700
Total cost of revenues							738,100			1,123,700
Gross profit		1,535,000			1,695,700			1,213,800			1,535,000

Operating expenses
Research and development		173,500			165,600			181,500			173,500
Sales and marketing		356,400			329,900			287,700			356,400
General and administrative		526,100			393,900			719,400			526,100
		1,056,000			889,400
Total operating expenses							1,188,600			1,056,000
Net income from operations		479,000			806,300			25,200			479,000

Other income (expenses)
Interest income		18,200			11,700			20,700			18,200
Interest expense and bank charges		(6,900	)		(10,800	)		(2,200	)		(6,900	)
		11,300			900
Total other income (expenses)							18,500			11,300
Net income before income taxes		490,300			807,200			43,700			490,300
Income taxes		(18,100	)		52,300			(5,700	)		(18,100	)
Net income	$	508,400		$	754,900		$	49,400		$	508,400

Net income per common share
Basic	$	.01		$	.01		$	.00		$	.01
Diluted	$	.01		$	.01		$	.00		$	.01

Weighted average common shares outstanding
Basic		64,052,777			59,443,207			67,436,153			64,052,777
Diluted		64,172,276			59,836,570			67,436,153			64,172,276


	Common stock				Paid-in		Accumulated					Common stock						Paid-in			Accumulated
	Shares		Amount		Capital		Deficit			Total		Shares			Amount			Capital			Deficit				Total

Balance – January 1, 2019		58,616,716	$	586,200	$	12,440,000	$	(11,059,500	)	$	1,966,700

Issuance of common stock		720,000		7,100		18,300					25,400

Conversion of debentures and accrued interest to common stock		1,707,982		17,100		25,600					42,700

Net income								754,900			754,900
Balance – December 31, 2019		61,044,698		610,400		12,483,900		(10,304,600	)		2,789,700
Balance – January 1, 2020												61,044,698		$	610,400		$	12,483,900		$	(10,304,600	)		$	2,789,700

Conversion of debentures and accrued interest to common stock		5,758,992		57,600		86,400					144,000		5,758,992			57,600			86,400							144,000

Exercise of warrants		550,000		5,500		5,500					11,000		550,000			5,500			5,500							11,000

Net income								508,400			508,400											508,400				508,400
Balance – December 31, 2020		67,353,690	$	673,500	$	12,575,800	$	(9,796,200	)	$	3,453,100		67,353,690			673,500			12,575,800			(9,796,200	)			3,453,100

Exercise of warrants												141,365			1,500			1,300							2,800

Net income																					49,400				49,400
Balance – December 31, 2021												67,495,055		$	675,000		$	12,577,100		$	(9,746,800	)		$	3,505,300


Computation of Basic and Diluted Weighted Average Common Shares Outstanding
	2020		2019		2021		2020
Basic shares outstanding		64,052,777		59,443,207		67,436,153		64,052,777
Incremental shares from assumed conversion of warrants		119,499		393,363		—		119,499
Diluted shares outstanding		64,172,276		59,836,570		67,436,153		64,172,276


State Income Tax Expense
	Year ended December 31						Year ended December 31
	2020			2019			2021				2020
Current state taxes	$	29,400		$	52,400		$	(5,700	)		$	29,300
Deferred state taxes		(47,400	)		–			—				(47,400	)
	$	(18,000	)	$	52,400
Income tax expense						$	(5,700	)		$	(18,100	)

Reconciliation of the Statutory Fedreal Rate
	2021						2020
	Amount			%			Amount			%

Income tax at U.S. federal income tax rate	$	9,700			21		$	106,700			21

State tax net of federal tax effect		(2,600	)		(5	)		(18,100	)		(4	)

Other		(13,800	)		(30	)		15,800			3

Increase in (utilization of ) operating losses		1,000			2			(122,500	)		(24	)
	$	(5,700	)		(12	)	$	(18,100	)		(4	)


Deferred Tax Assets and Liabilities
	2020			2019				2021				2020

Deferred tax asset for NOL carryforwards	$	456,700		$	454,200			$	457,700			$	456,700

Deferred tax liability - other		–			(47,400	)
Valuation allowance		(456,700	)		(454,200	)			(457,700	)			(456,700	)
	$	–		$	(47,400	)
Deferred tax liability							$	—			$	—


Maturities of Lease Liabilities
	Operating Leases			Operating Leases
Year ending December 31
2021	$	53,100
2022		54,600		$	54,600
2023		56,200			56,200
2024		18,900			18,900
Total lease payments		182,800			129,700
Less imputed interest		(22,500	)		(13,900	)
Total	$	160,300		$	115,800

Outstanding Warrants
			Weighted
		Exercise	Average
	Number of	Price Range	Exercise
	Shares	Per Share	Price
Outstanding at December 31, 2019	691,365	$0.02	$0.02
Warrants exercised	550,000	0.02	0.02
Outstanding at December 31, 2020	141,365	0.02	0.02
Warrants exercised	141,365	0.02	0.02
Outstanding at December 31, 2021	—	0.00	0.00


Revenues from Non-affiliated Customers
	Year ended December 31				Year ended December 31
	2020		2019		2021			2020
Customer A		62%		55%		48	%		62	%
Customer B		16%		18%		27	%		16	%


Non-affiliated Customers with Accounts Receivable More Than 10%
	December 31				December 31
	2020		2019		2021			2020
Customer A		25%		26%		21	%		25	%
Customer B		65%		67%		74	%		65	%


Revenue by Geographic Region
	Year ended December 31				Year ended December 31
	2020		2019		2021		2020
North America	$	701,600	$	856,300	$	812,800	$	701,600
South America		2,200		–		4,100		2,200
Europe		–		600
Asia		1,845,500		1,630,500		1,041,300		1,845,500
Australia		109,400		50,000		93,700		109,400
	$	2,658,700	$	2,537,400	$	1,951,900	$	2,658,700

Exhibit
~~Exhibit~~ Number	Description	Location
~~Number~~	~~Description~~	~~Location~~
3.1
~~3.1~~	Amended and Restated Articles of Incorporation	Incorporated by reference to the Company’s Form 10-Q filed on November 14, 2008
3.2	Second Amended and Restated Bylaws, Dated January 28, 2022	Incorporated by reference to the Company’s Form 8-K filed on February 2, 2022
3.3	Articles Supplementary relating to Nocopi Technologies, Inc.’s election to be subject to Sections 3-803, 3-804(a), 3-804(b) and 3-804(c) of the Maryland General Corporation Law	Incorporated by reference to the Company’s Form 8-K filed on ~~March 12, 2019~~October 29, 2021
4.1	Form of Certificate of Common Stock	Incorporated by reference to the Company’s Annual Report on Form 10-KSB filed on April 7, 2006
4.2	Securities registered under Section 12 of the Exchange Act	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 30, 2020
10.1†	Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan	Incorporated by reference to the Company’s Annual Report on Form 10-KSB filed on April 15, 1999
10.2	Director Indemnification Agreement	Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB filed on November 15, 1999
10.3	Officer Indemnification Agreement	Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB filed on November 15, 1999
10.4†	Employment Agreement with Michael A. Feinstein, M.D.	Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008
10.5†	Employment Agreement Amendment - Michael A. Feinstein, M.D.	Incorporated by reference to the Company’s Form 8-K filed on December 17, 2019
10.6†	Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 31, 2010
10.7†	Employment Agreement with Terry W. Stovold	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 30, 2012
10.8	Form of Convertible Debenture Purchase Agreement and Exhibits	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on September 11, 2015
10.9	Form of Letter Agreement re: Convertible Debenture Purchase Agreement Election	Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2019
10.10	Lease Agreement dated December 12, 2013 relating to premises at 480 Shoemaker Road, King of Prussia, PA 19406	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on September 11, 2015
10.11	Lease Extension Agreement dated September 28, 2018	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 29, 2019
10.12	Business Loan Agreement, Promissory Note and Commercial Security Agreement dated November 28, 2018 between the Company and Santander Bank	Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 29, 2019

10.13	Form of Letter Agreement re: Convertible Debenture Purchase Agreement Election	Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2019
14.1	Code of Ethics	Incorporated by reference to the Company’s Annual Report on Form 10-KSB filed on March 31, 2005
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a)	Filed herewith


31.2	Certification of Chief Financial Officer required by Rule 13a-14(a)	Filed herewith
32.1	Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Furnished herewith
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)